[Beta-2 specificity of bronchially active sympathomimetics using capillary laser Doppler sonography exemplified by tulobuterol].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000328:Adult; D000402:Airway Obstruction / Q000188:drug therapy*; D000420:Albuterol / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D012130:Respiratory Hypersensitivity / Q000188:drug therapy*; D012212:Rheology; D013726:Terbutaline / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; C010809:tulobuterol; D013726:Terbutaline; D000420:Albuterol
Untersuchungen zur beta-2-Spezifität bronchial wirksamer Sympathikomimetika mittels Kapillar-Laser-Doppler-Sonographie (KLDS) am Beispiel des Tulobuterols.